Discovery 'May Lead To Genetic Test in Advance Prediction of Heart Failure’

Fortunate string of events that happened in a new study could result in a genetic test that can help predict heart failure in certain people beforehand.

It started when members of Medical scientist Howard Young's team, Delaine Ceholski and Cathy Trieber, discovered a new mutation in a protein called phospholamban, which they predicted would cause the heart to be less responsive to changes in the body and eventually lead to heart failure.

Congestive Heart Failure (Congestive Cardiac Failure) Current Management
Congestive heart failure (CHF) is a condition in which the heart fails to work adequately as a pump that can deliver oxygen rich blood to the body.

One month after submitting their paper to the Journal of Biological Chemistry for review, their work was validated when - in completely separate research - the mutation was found in two patients in Brazil.

"We predicted it exactly," Young said.

"It's interesting, because as basic researchers you feel like you have to constantly defend your research and how relevant test-tube work is to patients... and then one day, to our surprise, we were right.

Heart Failure More Common in Type 1 Diabetics With Poor Blood Sugar Control
Recent study indicates that type 1 diabetics with very poor blood sugar control are at a higher risk for developing heart failure and this happens at a lower age than the general population.

"I expected to be right, but not in the time frame that occurred. It happened quickly," he said.

Shortly after that, Young, who is an associate professor in the Faculty of Medicine 'n' Dentistry's Department of Biochemistry and researcher with the National Institute of Nanotechnology, was asked to speak at the Centennial Lectures, a speakers series offered by the faculty as a lead-up to the medical school's centennial year in 2013 to spotlight the translational work of its researchers.

Are Immigrants at a Risk of Increased Heart Failure?
A study has revealed the association of heart failure and immigration status. Immigrants with large waist circumference are at a risk of heart failure.

Young was paired with cardiologist and researcher Justin Ezekowitz of the Department of Medicine.

Each became interested in the work of the other, and now the two are pairing up to screen patients' blood samples for mutations in the phospholamban protein.

Is Telemonitoring in Patients With Heart Failure a Failure?
There is no reduction in the risk of readmission or death from any cause with telemonitoring as compared with usual care.

"If someone had asked me last September if we'd ever get into sequencing patients' genes and trying to discover mutants, I would say 'no, you're wrong,' " said Young. "But now we're very interested in starting large sequencing studies to try and find more mutations."

Through his research, Young thinks he has established good prediction models for heart disease.

If his research group finds a mutation in phospholamban through blood screening, Young believes he can predict the severity of the mutation and whether or not it will be associated with disease.

"It will be truly personalized medicine," Young said.

"If we know they [patients] have a mutation before disease, monitoring and early treatment could improve and extend the quality of life for these patients," he said.

Young and researchers in his lab will look at blood samples from about 750 patients at the Mazankowski Alberta Heart Institute.

Young expects to find at least two or three people with a mutation in phospholamban.

They'll also look for other mutations that have not been previously discovered.

"There's a related protein to phospholamban in the skeletal muscle and the atria of the heart, so we're branching out and going to see if we can identify new mutations, because no mutations have been identified in that protein," he added.

Source-ANI